1. Kovacs J.A., Gill V.J., Meshnick S., Masur H. New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. n.d.
2. American college of rheumatology/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody–associated vasculitis;Chung;Arthritis Care Res,2021
3. Pneumocystis jiroveci pneumonia in giant cell arteritis: a case series;Kermani;Arthritis Care Res,2011
4. Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective, double-cohort study;Schmidt;Arthritis Rheumatol,2016
5. Berger C.T., Greiff V., John S., Koenig K.F., Bigler M.B., Recher M., et al. Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study. Clin Exp Rheumatol n.d.;33:S-122-5.